Results 181 to 190 of about 27,419 (207)

A statistical methodology for postmarketing surveillance of adverse drug reaction reports.

Statistics in Medicine, 1988
P. Norwood, A. Sampson
semanticscholar   +1 more source

Safety of oral terbinafine : Results of a postmarketing surveillance study in 25 884 Patients

, 1997
M. Hall, C. Monka, P. Krupp, D. O'Sullivan   +3 more
semanticscholar   +1 more source

FDA's Unimproved Enforcement of Postmarketing Requirements and Commitments: Implications for Providers and Patients

Research in Social and Administrative Pharmacy, 2020
Daniel G Dauner, Kim Nichols Dauner
exaly  

Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU

British Journal of Clinical Pharmacology, 2016
Jarno Hoekman, Aukje K Mantel-Teeuwisse
exaly  

Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002

Current Medical Research and Opinion, 2009
Frank G Bottone, William T Barry
exaly  

The Cluster Design for the Postmarketing Stability Surveillance Program

, 2005
F. Verbon, E. R. van den Heuvel, C. Vermaat   +2 more
semanticscholar   +1 more source

Postmarketing Surveillance: A Brief Synopsis of Its History and Current Direction

, 1996
D. Palan
semanticscholar   +1 more source

Postmarketing surveillance for drug abuse

Drug and Alcohol Dependence, 2003
Cynthia L Arfken, Theodore J Cicero
exaly  

1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

American Journal of Emergency Medicine, 2000
T. Litovitz, W. Klein‐Schwartz, S. White, D. J. Cobaugh, J. Youniss, A. Drab, B. E. Benson   +6 more
semanticscholar   +1 more source

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2011
Masayoshi Harigai, Naoki Ishiguro, Junnosuke Ryu   +2 more
exaly